Soumit Roy
Stock Analyst at Jones Trading
(3.51)
# 873
Out of 5,148 analysts
46
Total ratings
34.29%
Success rate
12.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $3.24 | +116.05% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $2.29 | +205.68% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $3.23 | +209.60% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $4.53 | - | 1 | Oct 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Hold | n/a | $0.99 | - | 2 | Sep 15, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $57.76 | -13.43% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $5.97 | +251.76% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $23.18 | +72.56% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $29.50 | -8.47% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.53 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.02 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $3.89 | +285.60% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.84 | +71.23% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $28.69 | +18.51% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $1.70 | +2,017.65% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.83 | +1,030.74% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $13.84 | -34.97% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $13.88 | +22.48% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.15 | +504.65% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $7.29 | +777.91% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.32 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.53 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $15.99 | +62.60% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $13.42 | +421.61% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $53.47 | -81.30% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.57 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $11.60 | +589.66% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.93 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $0.55 | +58,081.82% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.33 | +18,606.70% | 1 | Feb 24, 2021 |
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $3.24
Upside: +116.05%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.29
Upside: +205.68%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $3.23
Upside: +209.60%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $4.53
Upside: -
aTyr Pharma
Sep 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.99
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $57.76
Upside: -13.43%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $5.97
Upside: +251.76%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $23.18
Upside: +72.56%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $29.50
Upside: -8.47%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.53
Upside: -
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.02
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $3.89
Upside: +285.60%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $5.84
Upside: +71.23%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $28.69
Upside: +18.51%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $1.70
Upside: +2,017.65%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.83
Upside: +1,030.74%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $13.84
Upside: -34.97%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $13.88
Upside: +22.48%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.15
Upside: +504.65%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $7.29
Upside: +777.91%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.32
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.53
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $15.99
Upside: +62.60%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $13.42
Upside: +421.61%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $53.47
Upside: -81.30%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.57
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $11.60
Upside: +589.66%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.93
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $0.55
Upside: +58,081.82%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.33
Upside: +18,606.70%